NEW YORK – Cepheid and Sherlock Biosciences said on Friday that they have formed a research collaboration to develop new molecular diagnostic tests, using Sherlock Biosciences' CRISPR-based engineering biology platform SHERLOCK to design tests to run on Cepheid's GeneXpert systems.